Cargando…
Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial
In 2020, the American Society of Hematology published evidence-based guidelines for cerebrovascular disease in individuals with sickle cell anemia (SCA). Although the guidelines were based on National Institutes of Health–sponsored randomized controlled trials, no cost-effectiveness analysis was com...
Autores principales: | Hsu, Peter, Gay, James C., Lin, Chyongchiou J., Rodeghier, Mark, DeBaun, Michael R., Cronin, Robert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153054/ https://www.ncbi.nlm.nih.gov/pubmed/34607344 http://dx.doi.org/10.1182/bloodadvances.2021004864 |
Ejemplares similares
-
Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria
por: Abdullahi, Shehu U., et al.
Publicado: (2023) -
Silent infarction in sickle cell disease is associated with brain volume loss in excess of infarct volume
por: Jones, R. Sky, et al.
Publicado: (2023) -
A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD
por: Cronin, Robert M., et al.
Publicado: (2023) -
Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial
por: Abdullahi, Shehu U., et al.
Publicado: (2023) -
The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry
por: Schwab, Marisa E., et al.
Publicado: (2022)